European Panel Gives Positive Opinion on Celgene Cancer Drug

Celgene said Friday a European regulatory committee has given a favorable opinion of its blood-cancer drug, a positive indicator the European Commission could approve the drug for use in untreated cases.



from WSJ.com: US Business http://ift.tt/1JgQak3

via IFTTT